Gianluca Torregrossa
Watch the on‑demand recording of this expert‑led webinar focused on the contemporary management of atrial fibrillation (AF) and left atrial appendage (LAA). In this session, leading international cardiac surgeons shared clinical evidence, guideline perspectives, and...
This case describes a robotic left atrial appendage occlusion (LAAO) performed at a specialized institution that receives patients who are poor candidates for percutaneous left atrial appendage (LAA) devices. These...
At the 2024 EACTS Annual Meeting, CTSNet senior editors set out to interview the most knowledgeable CT surgeons from around the world. Stay tuned for more interviews from the meeting....
At the 2023 International Coronary Congress, four surgeons presented their biggest mistakes in CABG surgery and how they went about fixing them. They emphasized the importance of surgeons sharing their...
At the 2023 International Coronary Congress, five experts made presentations on hot topics in coronary surgery. Subjects included the future of non-surgical management of coronary disease, the future of coronary...
Watch the Medtronic Global Grand Rounds. Marc Ruel, M.D., Donna May Kimmaliardjuk, M.D., and Gianluca Torregrossa, M.D., discuss the importance of OPCAB procedures and gaining adoption and building an OPCAB...
Robotic approach allows to harvest bilateral thoracic arteries using 5 ports (8 or 12 mm) in the left chest with no thoracotomy or sternotomy. This allows for a quick recovery...
The Memo 4D System by LivaNova is a novel semi-rigid annuloplasty ring. Ideal for the minimally invasive approach, this ring allows neochord implantation without physical measurement or further adjustments in...
A previously healthy 58-year-old man presented to the emergency department with 8/10 chest pain radiating to his back. His blood pressure was 160/100 mm Hg. The electrocardiogram showed anterolateral ST...
The CardioWest™ Total Artificial Heart (TAH) is a biventricular orthotopic pneumatic pulsatile pump that totally replaces the native ventricles and valves and is currently approved as a bridge to heart...







